Evaluation of commercially available high-throughput SARS-CoV-1 2 serological assays for serosurveillance and related applications
Stone M, Grebe PE, Sulaeman H, Germanio CD, Dave H, Kelly K, Biggerstaff BJ, Crews BO, Tran N, Jerome KR, Deny TN, Hogema B, Jones JM, Thornburg NJ, Simmons G, Krajden M, Kleinman S, Dumont LJ, Busch MP
